213Bi-anti-EGFR radioimmunoconjugates and X-ray irradiation trigger different cell death pathways in squamous cell carcinoma cells

Anja Pickhard, Guido Piontek, Christof Seidl, Samuel Kopping, Birgit Blechert, Martin Mißlbeck, Gero Brockhoff, Frank Bruchertseifer, Alfred Morgenstern, Markus Essler

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

Introduction: Treatment of patients with squamous cell carcinoma of head and neck is hampered by resistance of tumor cells to irradiation. Additional therapies enhancing the effect of X-ray irradiation may be beneficial. Antibodies targeting EGFR have been shown to improve the efficacy of radiation therapy. Therefore, we analyzed cytotoxicity of 213Bi-anti-EGFR immunoconjugates in combination with X-ray irradiation. Methods: The monoclonal anti-EGFR antibody matuzumab was coupled to CHX-A"-DTPA forming stable complexes with 213Bi. Cytotoxicity of X-ray radiation, of treatment with 213Bi-anti-EGFR monoclonal antibodies (MAb) or of a combined treatment regimen was assayed using cell proliferation and colony formation assays in UD-SCC5 cells. Key proteins of cell-cycle arrest and cell death were examined by Western blot analysis. Cell cycle analysis was performed by flow cytometry. DNA double-strand breaks were detected via γH2AX and quantified using Definiens™ software. Results: Irradiation with X-rays or treatment with 213Bi-anti-EGFR-MAb resulted in median lethal dose (LD50) values of 12Gy or 130kBq/mL, respectively. Treatment with 37kBq/mL of 213Bi-anti-EGFR-MAb or 2Gy of X-rays had only little effect on colony formation of UD-SCC5 cells. In contrast, a combined treatment regimen (37kBq/mL plus 2Gy) significantly decreased colony formation and enhanced the formation of DNA double-strand breaks. As revealed by flow cytometry, radiation treatments caused accumulation of cells in the G0/G1 phase. Both treatment with 213Bi-anti-EGFR immunoconjugates and application of the combined treatment regimen triggered activation of genes of signaling pathways involved in cell-cycle arrest and induction of apoptosis like p21/Waf, GADD45, Puma and Bax, which were only marginally modulated by X-ray irradiation of cells. Conclusions: 213Bi-anti-EGFR-MAb enhances cytotoxicity of X-ray irradiation in UD-SCC5 cells most probably due to effective induction of DNA double-strand breaks. Induction of genes involved in cell-cycle arrest and cell death is almost exclusively due to 213Bi-anti-EGFR-MAb and seems to be independent of p53 function.

Original languageEnglish
Pages (from-to)68-76
Number of pages9
JournalNuclear Medicine and Biology
Volume41
Issue number1
DOIs
StatePublished - Jan 2014

Keywords

  • Apoptosis
  • Cell-cycle arrest
  • Cytotoxicity
  • Head and neck squamous cell carcinoma
  • Radioimmunotherapy
  • UD-SCC5 cells
  • α-emitter Bi

Fingerprint

Dive into the research topics of '213Bi-anti-EGFR radioimmunoconjugates and X-ray irradiation trigger different cell death pathways in squamous cell carcinoma cells'. Together they form a unique fingerprint.

Cite this